This leaflet answers some common questions about Cyclosporin Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

The average daily volume is approximately 1.1 million shares, which means the Swiss listing is most definitely the most liquid listing to trade in Sandoz stock. The current market cap is ...

Watches and Wonders 2025 is just a few days away, so today, on Fratello Talks, we’re making our predictions, voicing our wishes, and expressing our fears for the week ahead. Nacho, RJ, and Lex are ...

A couple of weeks ago, the British Watchmakers’ Day occurred in London. Not only was it a day to get to know almost 45 British watch brands but also a chance for people to get their hands on one of ...

Epicrispr Biotechnologies has raised $68 million in pursuit of a first-of-its-kind genetic medicine for a rare neuromuscular disorder called facioscapulohumeral muscular dystrophy. EPI-321, the ...

Amjevita launched in Europe in 2018 as Amgevita, bringing in $460 million in that market alone for 2022. Sandoz recorded double-digit growth for its biosimilar portfolio thanks to adalimumab copy ...

President Donald Trump on Tuesday issued an executive order against Jenner & Block, growing his list of Big Law targets. The order against Jenner is similar to the actions taken against Paul Weiss ...

Merck was one of the pioneers of the cholesterol-lowering statins that launched in the 1980s and 1990s and changed medical practice. But it hasn’t been as successful with cholesterol medicines since ...

Sandoz Inc. and Boehringer Ingelheim International GmbH agreed to a federal court judgment that Sandoz’s proposed copies of Ofev don’t infringe two patents for the rare-lung-disease treatment, ...

President Donald Trump is once again going after Big Law, this time with a memorandum that urges the Justice Department and homeland security secretary to explore sanctions against firms engaged ...

Stock levels have been increased in order to be prepared for disruptions. The generics manufacturer Sandoz also fears negative effects: Unlike the two Basel-based pharmaceutical giants Roche and ...